Stocks and Investing Stocks and Investing
Mon, November 15, 2021

Matthew Harrison Maintained (AKRO) at Hold with Increased Target to $29 on, Nov 15th, 2021


Published on 2024-10-27 18:38:46 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Akero Therapeutics, Inc." (AKRO) at Hold with Increased Target from $27 to $29 on, Nov 15th, 2021.

Matthew has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aspen Mori of "B of A Securities" Initiated at Strong Buy and Held Target at $40 on, Friday, September 10th, 2021
Contributing Sources